Overexpression of METTL16 improved bone growth and alleviated ferroptosis of chondrocytes by increasing m6A modification of GPX4 mRNA and thus GPX4 expression in chondrocytes. The METTL16/GPX4 axis may be a promising therapeutic approach for ACH treatment.
Li et al. (Tue,) studied this question.